Open AccessComparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
Author(s) -
Hanmant Barkate,
Piyush M. Patel,
Dimple Shah,
Falgun Indravadan Vyas
Publication year - 2018
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_321_16
Subject(s) - fenofibrate , rosuvastatin , medicine , fixed dose combination , dyslipidemia , rosuvastatin calcium , gastroenterology , randomized controlled trial , triglyceride , urology , cholesterol , clinical endpoint , obesity
This study was conducted to evaluate the safety and efficacy of fixed-dose combination (FDC) of rosuvastatin and choline fenofibrate in comparison to rosuvastatin and fenofibrate FDC among Indian patients of mixed dyslipidemia. This would be a first study evaluating FDC of rosuvastatin and choline fenofibrate in Indian population.